An investigation into the two-stage meta-analytic copula modelling approach for evaluating time-to-event surrogate endpoints which comprise of one or more events of interest-Reference-Cited by-同舟云学术

An investigation into the two-stage meta-analytic copula modelling approach for evaluating time-to-event surrogate endpoints which comprise of one or more events of interest

Published:2017-05-19 Issue:5 Volume:16 Page:322-333
ISSN:1539-1604
Container-title:Pharmaceutical Statistics
language:en
Short-container-title:Pharmaceutical Statistics

Author:

Dimier Natalie¹²^ORCID,Todd Susan²

Affiliation:

1. Roche Products Ltd; Welwyn Garden City UK

2. Department of Mathematics and Statistics; University of Reading; Reading UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Reference35 articles.

1. Accelerated Approval of Oncology Products: The Food and Drug Administration Experience

2. Surrogate endpoints in clinical trials: Definition and operational criteria

3. Statistical validation of intermediate endpoints for chronic diseases

4. ESTIMATING THE PROPORTION OF TREATMENT EFFECT EXPLAINED BY A SURROGATE MARKER

5. Bayesian estimation of the proportion of treatment effect captured by a surrogate marker

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis;The Lancet Oncology;2024-03

2. Surrogate endpoint evaluation using data from one large global randomized controlled trial;BMC Medical Informatics and Decision Making;2021-05-20

3. Assessment of the information theory approach to evaluating time‐to‐event surrogate and true endpoints in a meta‐analytic setting;Pharmaceutical Statistics;2020-11-03

4. A Systematic Review and Recommendation for Reporting of Surrogate Endpoint Evaluation Using Meta-analyses;JNCI Cancer Spectrum;2019-02-06